1. Pharmaceuticals and Drug Development

Unicycive Therapeutics Announces Receipt of Complete Response Letter for Oxylanthanum Carbonate for the Treatment of Hyperphosphatemia in Patients with Chronic Kidney Disease on Dialysis

Written by Posted on Less than 0 min read

LOS ALTOS, Calif., June 30, 2025 (GLOBE NEWSWIRE) — Unicycive Therapeutics, Inc. (“Unicycive” or the “Company”) (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease…

Member since

More from Admin

Scientists uncover new way viruses fight back against bacteria
  1. Life Sciences

Tiny roundworms carve out unique parasitic niche inside pseudoscorpion’s protective covering

The early worm gets the arachnid, fossil research by an Oregon State University scientist has shown. In a parasitic first, a Baltic amber specimen has revealed that millions of years ago tiny worms known as nematodes were living inside of and feeding on the outer protective layer of pseudoscorpions. “This is very strange,” said George […]
Written by
Scientists uncover new way viruses fight back against bacteria
  1. Life Sciences

New Zealand’s flightless birds are retreating to moa refuges

Researchers have found New Zealand’s endangered flightless birds are seeking refuge in the locations where six species of moa last lived before going extinct. An international team of researchers, led by scientists from the University of Adelaide, used fossils and computer modelling to make the discovery, shedding light on a mystery with important conservation benefits. […]
Written by
Scientists uncover new way viruses fight back against bacteria
  1. Life Sciences

AI-designed DNA controls genes in healthy mammalian cells for first time

A study published today in the journal Cell marks the first reported instance of generative AI designing synthetic molecules that can successfully control gene expression in healthy mammalian cells. Researchers at the Centre for Genomic Regulation (CRG) created an AI tool which dreams up DNA regulatory sequences not seen before in nature. The model can […]
Written by
Scientists uncover new way viruses fight back against bacteria
  1. Life Sciences

Genetic switch could help control leaf growth in poor soils

A new study has identified a genetic circuit in plants that controls individual leaf growth and allows the plants to adapt to their environment. The findings could help the development of more drought-resistant crops. Scientists from the University of Nottingham’s School of Biosciences investigated the growth of maizeleaves in plants cultivated in three different soils […]
Written by
Scientists uncover new way viruses fight back against bacteria
  1. Life Sciences

Forest restoration can boost people, nature and climate simultaneously

Forest restoration can benefit humans, boost biodiversity and help tackle climate change simultaneously, new research suggests. Restoring forests is often seen in terms of “trade-offs” — meaning it often focuses on a specific goal such as capturing carbon, nurturing nature or supporting human livelihoods. The new study, by the universities of Exeter and Oxford, found […]
Written by
Scientists uncover new way viruses fight back against bacteria
  1. Life Sciences

Large herbivores such as elephants, bison and moose contribute to tree diversity

Using global satellite data, a research team has mapped the tree cover of the world’s protected areas. The study shows that regions with abundant large herbivores in many settings have a more variable tree cover, which is expected to benefit biodiversity overall. Maintaining species-rich and resilient ecosystems is key to preserving biodiversity and mitigating climate […]
Written by
Scientists uncover new way viruses fight back against bacteria
  1. Life Sciences

Feeding grazing cattle seaweed cuts methane emissions by almost 40%

Seaweed is once again showing promise for making cattle farming more sustainable. A new study by researchers at the University of California, Davis, found that feeding grazing beef cattle a seaweed supplement in pellet form reduced their methane emissions by almost 40% without affecting their health or weight. The study was published today (Dec. 2) […]
Written by
Scientists uncover new way viruses fight back against bacteria
  1. Life Sciences

Study points to South America — not Mexico — as birthplace of Irish potato famine pathogen

Call it a mystery solved. North Carolina State University researchers firmly point the finger at the South American Andes Mountains as the place where the Irish potato famine pathogen, Phtytophthora infestans, originated. In a wide-ranging study of the genetic material found in P. infestans and other members of the Phytophthora species, the NC State researchers […]
Written by
Scientists uncover new way viruses fight back against bacteria
  1. Life Sciences

Researcher studies the power of native plants to combat road salt pollution

Salt pollution in freshwater is a growing global concern. Excessive salt harms plants, degrades soil, and compromises water quality. In urban areas, road salts used for de-icing during winter often wash into stormwater systems, posing health concerns and challenges for infrastructure. Specifically, salts can impact the processes like filtration and contaminate retention basins that are […]
Written by
Scientists uncover new way viruses fight back against bacteria
  1. Life Sciences

Nearly half of popular tropical plant group related to birds-of-paradise and bananas are threatened with extinction

A new analysis from researchers at the Smithsonian’s National Museum of Natural History reveals that nearly half of the genus Heliconia, a group of tropical plants popular for their bright, beak-shaped flowers, are threatened with extinction. The findings, published today, March 7, in the journal Plants, People, Planet, reveal that many of these imperiled plants […]
Written by
Scientists uncover new way viruses fight back against bacteria
  1. Life Sciences

Microorganisms can travel long distances in the troposphere

Analysis of air samples taken at altitudes of up to 3,000 metres above Japan has revealed the presence of a vast range of viable bacteria and fungi transported by air masses originating more than 2,000 kilometres away, in regions enriched with fertilisers and pesticides. The study, published in Proceedings of the National Academy of Sciences […]
Written by
Takeda Announces Topline Results of Phase 3 ADMIRE-CD II Trial of Alofisel® (darvadstrocel) in Complex Crohn’s Perianal Fistulas
  1. Pharmaceuticals and Drug Development

Ascendis Pharma Announces Extension of U.S. Food and Drug Administration Review Period for TransCon PTH for Adults with Hypoparathyroidism

Generic name: palopegteriparatideTreatment for: Hypoparathyroidism Ascendis Pharma Announces Extension of U.S. Food and Drug Administration Review Period for TransCon PTH for Adults with Hypoparathyroidism COPENHAGEN, Denmark, May 14, 2024 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND) today announced that the U.S. Food and Drug Administration (FDA) notified the Company that information submitted in response […]
Written by
Sociodemographic Disparities Seen in Quality of Life in Children With Hearing Loss
  1. Pharmaceuticals and Drug Development

Sociodemographic Disparities Seen in Quality of Life in Children With Hearing Loss

By Lori Solomon HealthDay Reporter TUESDAY, Oct. 31, 2023 — Race and ethnicity and neighborhood disadvantage are associated with hearing-related quality of life (QOL) in deaf or hard-of-hearing (DHH) children, according to a research letter published online Oct. 30 in JAMA Network Open. Brooke R. Warren, from the University of California in San Francisco, and […]
Written by
Takeda Announces Topline Results of Phase 3 ADMIRE-CD II Trial of Alofisel® (darvadstrocel) in Complex Crohn’s Perianal Fistulas
  1. Pharmaceuticals and Drug Development

FDA Grants Accelerated Approval for Tecelra (afamitresgene autoleucel) Cell Therapy for the Treatment of Synovial Sarcoma

FDA Grants Accelerated Approval for Tecelra (afamitresgene autoleucel) Cell Therapy for the Treatment of Synovial Sarcoma PHILADELPHIA & OXFORD, England–(BUSINESS WIRE) August 01, 2024 — Adaptimmune Therapeutics plc (NASDAQ: ADAP), a company working to redefine the treatment of solid tumor cancers with cell therapy, today announced U.S. Food and Drug Administration (FDA) accelerated approval of […]
Written by
Takeda Announces Topline Results of Phase 3 ADMIRE-CD II Trial of Alofisel® (darvadstrocel) in Complex Crohn’s Perianal Fistulas
  1. Pharmaceuticals and Drug Development

FDA Approves Yesafili (aflibercept-jbvf), an Interchangeable Biosimilar to Eylea

May 20, 2024 — The U.S. Food and Drug Administration (FDA) has approved Yesafili (aflibercept-jbvf), an interchangeable biosimilar to Eylea (aflibercept). Aflibercept products work by inhibiting vascular endothelial growth factor (VEGF) which prevents abnormal blood vessel growth within the eye. By blocking VEGF, aflibercept products can slow down or reduce damage to the retina and […]
Written by
  1. Biology

eIF5A controls mitoprotein import by relieving ribosome stalling at TIM50 translocase mRNA

Efficient import of nuclear-encoded proteins into mitochondria is crucial for proper mitochondrial function. The conserved translation factor eIF5A binds ribosomes, alleviating stalling at polyproline-encoding sequences. eIF5A impacts mitochondrial function across species, though the precise molecular mechanism is unclear. We found that eIF5A depletion in yeast reduces the translation and levels of the TCA cycle and […]
Written by
  1. Clinical

Approval for the First Dose Cohort in Phase 1a/b Clinical Trial of PMC-309 in Patients with Advanced or Metastatic Solid Tumors

DAEJEON, South Korea, July 8, 2024. PharmAbcine Inc., a clinical-stage biotech company focusing on next-generation antibody therapeutics, announced that PMC-309, VISTA-targeting immuno-oncology program, received safety approval for the first dose cohort (0.2mg/kg) in Phase 1a/b clinical trial for patients with advanced or metastatic solid tumors in Australia. The second dose cohort (0.5mg/kg) is currently ongoing. […]
Written by
  1. Clinical

Cadrenal Therapeutics Receives FDA Orphan Drug Designation for Tecarfarin for Prevention of Thromboembolism and Thrombosis in Sufferers with LVADs, RVADs, Biventricular Help Gadgets, and Whole Synthetic Hearts

PONTE VEDRA, Fla., April 9, 2024 — Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a biopharmaceutical firm growing tecarfarin, a late-stage novel oral and reversible anticoagulant (blood thinner) designed to forestall coronary heart assaults, strokes, and deaths as a consequence of blood clots in sufferers with uncommon cardiovascular circumstances, introduced immediately that the USA Meals and Drug […]
Written by
  1. Clinical

Accutar Biotechnology Receives FDA Fast Track Designation for AC699 in ER+ / HER2- Breast Cancer

CRANBURY, N.J.–(BUSINESS WIRE) Aug 14, 2024 –Accutar Biotechnology, Inc., a biotechnology company focusing on artificial intelligence (AI)-enabled drug discovery, announced today that the US Food and Drug Administration (FDA) has granted the investigation of AC699 a Fast Track designation for the treatment of patients with estrogen receptor (ER)-positive, human epidermal growth factor receptor-2 (HER2)-negative, estrogen […]
Written by
Next
No Comments
Leave a comment Cancel
Comments to: Unicycive Therapeutics Announces Receipt of Complete Response Letter for Oxylanthanum Carbonate for the Treatment of Hyperphosphatemia in Patients with Chronic Kidney Disease on Dialysis

Login

Welcome to Life Science News!
"Explore the Latest Discoveries and Breakthroughs in Life Science with Life Science News!"
Read Smart, Save Time
Pick all the topics you are interested in to fill your homepage with stories you'll love.
Join our community
Registration is closed.